Serge Lyashchenko, PharmD
Radiopharmacist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Associate Attending Radiopharmacist
I am a registered radiopharmacist specializing in the development of immunoPET and theranostics agents. I have been practicing radiopharmacy more than ten years.
Read more
My work focuses on safely using radiation to treat various diseases. I supervise the manufacturing of novel molecular imaging agents in MSK’s state-of-the-art Radiochemistry and Molecular Imaging Probe Core Facility. Additionally, I am actively involved in early agent development strategies with both academic and industry colleagues. These plans will ensure that new agents can move beyond first-in-human studies and possibly become the standard care in the future.
I am a member of the Investigation New Drug Committee, Radiology Quality Assurance Committee, Committee on Radiation, and Radioactive Drug Research Committee. With these groups, I ensure efficient and controlled development of molecular imaging agents, with the overarching goal of providing the best cancer care.
Working at MSK is especially rewarding because it involves collaboration with a broad range of multidisciplinary teams. I very much enjoy working with preclinical development teams because I can continuously generate new ideas.
A radiopharmacist, also known as a nuclear pharmacist, has special training in preparing radioactive drugs to use in treatments.
My Specialties
- Radiopharmacy
Education
- PharmD, Ernest Mario School of Pharmacy, Rutgers University
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Lyashchenko sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Lyashchenko’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Serge Lyashchenko discloses the following relationships and financial interests:
-
Evergreen Theragnostics
Equity; Professional Services and Activities (Uncompensated) -
International Atomic Energy Agency (IAEA)
Professional Services and Activities
-
University of California
Professional Services and Activities -
Y-mAbs Therapeutics, Inc.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
